{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:53:30Z","timestamp":1790985210334,"version":"4.1.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T042184\/1, MR\/Y034031\/1"],"award-info":[{"award-number":["MR\/T042184\/1, MR\/Y034031\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W006774\/1"],"award-info":[{"award-number":["MR\/W006774\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MRC LMS core funding","award":["MCA658-5TY60"],"award-info":[{"award-number":["MCA658-5TY60"]}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["218529\/Z\/19\/Z, 204841\/Z\/16\/Z"],"award-info":[{"award-number":["218529\/Z\/19\/Z, 204841\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/T013273\/1,BB\/W014890\/1"],"award-info":[{"award-number":["BB\/T013273\/1,BB\/W014890\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/R01356X\/1"],"award-info":[{"award-number":["BB\/R01356X\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer progression involves not only uncontrolled proliferation but also the strategic entry of tumour cells into reversible (quiescent) or irreversible (senescent) states of cell cycle arrest (G0). These states can give rise to rare persister-like cancer cells that survive hostile tumour microenvironment conditions, facilitating drug resistance, metastasis and disease relapse. Despite their importance, identifying and understanding the mechanisms regulating these cell populations remains challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We leveraged single-cell and spatially profiled primary breast tumours to quantify G0 arrest and proliferation decisions in cancer cells, revealing molecular and spatial features associated with proliferation-G0 dynamics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We uncovered a G0 persister-like state with reduced copy number alteration burden and hallmarks of dormancy, characterised by transcriptional reprogramming of stress response pathways and increased epithelial-mesenchymal plasticity. Spatial analyses revealed distinct ecological niches: G0 cells inhabited protective niches with complement pathway activity proximal to\n                      <jats:italic>CXCL10<\/jats:italic>\n                      +\u2009macrophages and myofibroblastic cancer-associated fibroblasts (CAFs), whereas proliferative zones were associated with\n                      <jats:italic>CLEC9A<\/jats:italic>\n                      +\u2009dendritic cells and PERK signalling, with distinct drug sensitivities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings highlight key principles underpinning G0-proliferation dynamics and niche specialisation in breast cancer, offering novel insights into the spatial drivers of tumour heterogeneity and evolution.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13073-026-01711-0","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:35:12Z","timestamp":1783607712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spatial ecology of breast cancer reveals co-evolution of proliferative and dormant niches"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8301-0172","authenticated-orcid":false,"given":"Cenk","family":"Celik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9031-1681","authenticated-orcid":false,"given":"William A.","family":"Weston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9529-3349","authenticated-orcid":false,"given":"Thais","family":"de Moraes-Lacerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7368-5149","authenticated-orcid":false,"given":"Eloise","family":"Withnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4321-9745","authenticated-orcid":false,"given":"Shi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3344-0336","authenticated-orcid":false,"given":"Tooki","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9625-2816","authenticated-orcid":false,"given":"John","family":"Labbadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6684-8114","authenticated-orcid":false,"given":"Alexis R.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2758-1741","authenticated-orcid":false,"given":"Maria","family":"Secrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"1","key":"1711_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"6","key":"1711_CR2","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ccell.2016.11.002","volume":"30","author":"S Ebinger","year":"2016","unstructured":"Ebinger S, Ozdemir EZ, Ziegenhain C, Tiedt S, Castro Alves C, Grunert M, et al. Characterization of rare, dormant, and therapy-resistant cells in acute lymphoblastic leukemia. Cancer Cell. 2016;30(6):849\u201362.","journal-title":"Cancer Cell"},{"issue":"1","key":"1711_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10555-023-10092-4","volume":"42","author":"F Francescangeli","year":"2023","unstructured":"Francescangeli F, De Angelis ML, Rossi R, Cuccu A, Giuliani A, De Maria R, et al. Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution. Cancer Metastasis Rev. 2023;42(1):197\u2013215.","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"1711_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41568-023-00642-x","volume":"24","author":"J Agudo","year":"2024","unstructured":"Agudo J, Aguirre-Ghiso JA, Bhatia M, Chodosh LA, Correia AL, Klein CA. Targeting cancer cell dormancy. Nat Rev Cancer. 2024;24(2):97\u2013104.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"1711_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41568-020-0263-0","volume":"20","author":"TG Phan","year":"2020","unstructured":"Phan TG, Croucher PI. The dormant cancer cell life cycle. Nat Rev Cancer. 2020;20(7):398\u2013411.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1711_CR6","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/s41416-023-02401-z","volume":"129","author":"WA Weston","year":"2023","unstructured":"Weston WA, Barr AR. A cell cycle centric view of tumour dormancy. Br J Cancer. 2023;129(10):1535\u201345.","journal-title":"Br J Cancer"},{"issue":"1","key":"1711_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10555-022-10073-z","volume":"42","author":"K Truskowski","year":"2023","unstructured":"Truskowski K, Amend SR, Pienta KJ. Dormant cancer cells: programmed quiescence, senescence, or both? Cancer Metastasis Rev. 2023;42(1):37\u201347.","journal-title":"Cancer Metastasis Rev"},{"issue":"11","key":"1711_CR8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41571-023-00815-5","volume":"20","author":"Y Pu","year":"2023","unstructured":"Pu Y, Li L, Peng H, Liu L, Heymann D, Robert C, et al. Drug-tolerant persister cells in cancer: the cutting edges and future directions. Nat Rev Clin Oncol. 2023;20(11):799\u2013813.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"1711_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.tips.2018.12.004","volume":"40","author":"A Recasens","year":"2019","unstructured":"Recasens A, Munoz L. Targeting cancer cell dormancy. Trends Pharmacol Sci. 2019;40(2):128\u201341.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"1711_CR10","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1038\/s41467-021-21884-z","volume":"12","author":"AF Aissa","year":"2021","unstructured":"Aissa AF, Islam A, Ariss MM, Go CC, Rader AE, Conrardy RD, et al. Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer. Nat Commun. 2021;12(1):1628.","journal-title":"Nat Commun"},{"issue":"7790","key":"1711_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41586-019-1884-x","volume":"577","author":"JY Xue","year":"2020","unstructured":"Xue JY, Zhao Y, Aronowitz J, Mai TT, Vides A, Qeriqi B, et al. Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition. Nature. 2020;577(7790):421\u20135.","journal-title":"Nature"},{"issue":"1","key":"1711_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","volume":"165","author":"S Malladi","year":"2016","unstructured":"Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y, et al. Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT. Cell. 2016;165(1):45\u201360.","journal-title":"Cell"},{"issue":"9","key":"1711_CR13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1158\/2159-8290.CD-15-0563","volume":"5","author":"A Ribas","year":"2015","unstructured":"Ribas A. Adaptive immune resistance: how cancer protects from immune attack. Cancer Discov. 2015;5(9):915\u20139.","journal-title":"Cancer Discov"},{"issue":"14","key":"1711_CR14","doi-asserted-by":"publisher","first-page":"5706","DOI":"10.1158\/0008-5472.CAN-09-2356","volume":"70","author":"D Barkan","year":"2010","unstructured":"Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, Davis AS, et al. Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res. 2010;70(14):5706\u201316.","journal-title":"Cancer Res"},{"issue":"9","key":"1711_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrc3793","volume":"14","author":"MS Sosa","year":"2014","unstructured":"Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14(9):611\u201322.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1711_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cell.2019.06.025","volume":"178","author":"HM Ashraf","year":"2019","unstructured":"Ashraf HM, Moser J, Spencer SL. Senescence evasion in chemotherapy: a sweet spot for p21. Cell. 2019;178(2):267\u20139.","journal-title":"Cell"},{"key":"1711_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/B978-0-12-397927-8.00010-5","volume":"65","author":"KJ Basile","year":"2012","unstructured":"Basile KJ, Aplin AE. Resistance to chemotherapy: short-term drug tolerance and stem cell-like subpopulations. Adv Pharmacol. 2012;65:315\u201334.","journal-title":"Adv Pharmacol"},{"issue":"1","key":"1711_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Primers. 2019;5(1):66.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"1711_CR19","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","volume":"186","author":"E Nolan","year":"2023","unstructured":"Nolan E, Lindeman GJ, Visvader JE. Deciphering breast cancer: from biology to the clinic. Cell. 2023;186(8):1708\u201328.","journal-title":"Cell"},{"issue":"1","key":"1711_CR20","doi-asserted-by":"publisher","first-page":"e23552","DOI":"10.1002\/dvg.23552","volume":"62","author":"P Aouad","year":"2024","unstructured":"Aouad P, Quinn HM, Berger A, Brisken C. Tumor dormancy: EMT beyond invasion and metastasis. Genesis. 2024;62(1):e23552.","journal-title":"Genesis"},{"issue":"1","key":"1711_CR21","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1038\/s41467-022-32523-6","volume":"13","author":"P Aouad","year":"2022","unstructured":"Aouad P, Zhang Y, De Martino F, Stibolt C, Ali S, Ambrosini G, et al. Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence. Nat Commun. 2022;13(1):4975.","journal-title":"Nat Commun"},{"issue":"5","key":"1711_CR22","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1158\/2159-8290.CD-23-1161","volume":"14","author":"D Rosano","year":"2024","unstructured":"Rosano D, Sofyali E, Dhiman H, Ghirardi C, Ivanoiu D, Heide T, et al. Long-term multimodal recording reveals epigenetic adaptation routes in dormant breast cancer cells. Cancer Discov. 2024;14(5):866\u201389.","journal-title":"Cancer Discov"},{"issue":"10","key":"1711_CR23","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.cell.2022.03.033","volume":"185","author":"P Baldominos","year":"2022","unstructured":"Baldominos P, Barbera-Mourelle A, Barreiro O, Huang Y, Wight A, Cho JW, et al. Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche. Cell. 2022;185(10):1694-708 e19.","journal-title":"Cell"},{"issue":"3","key":"1711_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41588-024-01654-5","volume":"56","author":"SB Malla","year":"2024","unstructured":"Malla SB, Byrne RM, Lafarge MW, Corry SM, Fisher NC, Tsantoulis PK, et al. Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer. Nat Genet. 2024;56(3):458\u201372.","journal-title":"Nat Genet"},{"issue":"25","key":"1711_CR25","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1016\/j.cell.2023.11.004","volume":"186","author":"X Qin","year":"2023","unstructured":"Qin X, Cardoso Rodriguez F, Sufi J, Vlckova P, Claus J, Tape CJ. An oncogenic phenoscape of colonic stem cell polarization. Cell. 2023;186(25):5554-68 e18.","journal-title":"Cell"},{"issue":"3","key":"1711_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.trecan.2023.11.003","volume":"10","author":"CJ Tape","year":"2024","unstructured":"Tape CJ. Plastic persisters: revival stem cells in colorectal cancer. Trends Cancer. 2024;10(3):185\u201395.","journal-title":"Trends Cancer"},{"issue":"1","key":"1711_CR27","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1038\/s41467-022-32448-0","volume":"13","author":"F Antonica","year":"2022","unstructured":"Antonica F, Santomaso L, Pernici D, Petrucci L, Aiello G, Cutarelli A, et al. A slow-cycling\/quiescent cells subpopulation is involved in glioma invasiveness. Nat Commun. 2022;13(1):4767.","journal-title":"Nat Commun"},{"issue":"3","key":"1711_CR28","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1371\/journal.pbio.0040083","volume":"4","author":"HA Coller","year":"2006","unstructured":"Coller HA, Sang L, Roberts JM. A new description of cellular quiescence. PLoS Biol. 2006;4(3):e83.","journal-title":"PLoS Biol"},{"issue":"3","key":"1711_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.devcel.2020.09.029","volume":"55","author":"O Marescal","year":"2020","unstructured":"Marescal O, Cheeseman IM. Cellular mechanisms and regulation of quiescence. Dev Cell. 2020;55(3):259\u201371.","journal-title":"Dev Cell"},{"key":"1711_CR30","doi-asserted-by":"publisher","first-page":"14728","DOI":"10.1038\/ncomms14728","volume":"8","author":"AR Barr","year":"2017","unstructured":"Barr AR, Cooper S, Heldt FS, Butera F, Stoy H, Mansfeld J, et al. DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression. Nat Commun. 2017;8:14728.","journal-title":"Nat Commun"},{"issue":"10","key":"1711_CR31","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1073\/pnas.1715345115","volume":"115","author":"FS Heldt","year":"2018","unstructured":"Heldt FS, Barr AR, Cooper S, Bakal C, Novak B. A comprehensive model for the proliferation-quiescence decision in response to endogenous DNA damage in human cells. Proc Natl Acad Sci U S A. 2018;115(10):2532\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"1711_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ejcb.2016.07.004","volume":"95","author":"Y Attieh","year":"2016","unstructured":"Attieh Y, Vignjevic DM. The hallmarks of CAFs in cancer invasion. Eur J Cell Biol. 2016;95(11):493\u2013502.","journal-title":"Eur J Cell Biol"},{"issue":"7","key":"1711_CR33","doi-asserted-by":"publisher","first-page":"e28332","DOI":"10.1016\/j.heliyon.2024.e28332","volume":"10","author":"M Rakina","year":"2024","unstructured":"Rakina M, Larionova I, Kzhyshkowska J. Macrophage diversity in human cancers: New insight provided by single-cell resolution and spatial context. Heliyon. 2024;10(7):e28332.","journal-title":"Heliyon"},{"issue":"7894","key":"1711_CR34","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41586-021-04278-5","volume":"601","author":"SJ Sammut","year":"2022","unstructured":"Sammut SJ, Crispin-Ortuzar M, Chin SF, Provenzano E, Bardwell HA, Ma W, et al. Multi-omic machine learning predictor of breast cancer therapy response. Nature. 2022;601(7894):623\u20139.","journal-title":"Nature"},{"issue":"9","key":"1711_CR35","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53(9):1334\u201347.","journal-title":"Nat Genet"},{"issue":"1","key":"1711_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13059-023-02963-4","volume":"24","author":"AJ Wiecek","year":"2023","unstructured":"Wiecek AJ, Cutty SJ, Kornai D, Parreno-Centeno M, Gourmet LE, Tagliazucchi GM, et al. Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer. Genome Biol. 2023;24(1):128.","journal-title":"Genome Biol"},{"issue":"5","key":"1711_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41587-020-00795-2","volume":"39","author":"R Gao","year":"2021","unstructured":"Gao R, Bai S, Henderson YC, Lin Y, Schalck A, Yan Y, et al. Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. Nat Biotechnol. 2021;39(5):599\u2013608.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"1711_CR38","doi-asserted-by":"publisher","first-page":"e107333","DOI":"10.15252\/embj.2020107333","volume":"40","author":"B Pal","year":"2021","unstructured":"Pal B, Chen Y, Vaillant F, Capaldo BD, Joyce R, Song X, et al. A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast. EMBO J. 2021;40(11):e107333.","journal-title":"EMBO J"},{"issue":"9","key":"1711_CR39","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41422-020-0355-0","volume":"30","author":"J Qian","year":"2020","unstructured":"Qian J, Olbrecht S, Boeckx B, Vos H, Laoui D, Etlioglu E, et al. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling. Cell Res. 2020;30(9):745\u201362.","journal-title":"Cell Res"},{"issue":"7873","key":"1711_CR40","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41586-021-03796-6","volume":"596","author":"Y Oren","year":"2021","unstructured":"Oren Y, Tsabar M, Cuoco MS, Amir-Zilberstein L, Cabanos HF, Hutter JC, et al. Cycling cancer persister cells arise from lineages with distinct programs. Nature. 2021;596(7873):576\u201382.","journal-title":"Nature"},{"issue":"8","key":"1711_CR41","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","volume":"54","author":"D Barkley","year":"2022","unstructured":"Barkley D, Moncada R, Pour M, Liberman DA, Dryg I, Werba G, et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat Genet. 2022;54(8):1192\u2013201.","journal-title":"Nat Genet"},{"key":"1711_CR42","unstructured":"10X Genomics I. 10X Genomics, Inc.; Available from: https:\/\/www.10xgenomics.com\/datasets."},{"issue":"1","key":"1711_CR43","doi-asserted-by":"publisher","first-page":"8353","DOI":"10.1038\/s41467-023-43458-x","volume":"14","author":"A Janesick","year":"2023","unstructured":"Janesick A, Shelansky R, Gottscho AD, Wagner F, Williams SR, Rouault M, et al. High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis. Nat Commun. 2023;14(1):8353.","journal-title":"Nat Commun"},{"issue":"7667","key":"1711_CR44","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nature23306","volume":"548","author":"DR Robinson","year":"2017","unstructured":"Robinson DR, Wu YM, Lonigro RJ, Vats P, Cobain E, Everett J, et al. Integrative clinical genomics of metastatic cancer. Nature. 2017;548(7667):297\u2013303.","journal-title":"Nature"},{"issue":"13","key":"1711_CR45","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573-87 e29.","journal-title":"Cell"},{"key":"1711_CR46","doi-asserted-by":"publisher","first-page":"baz046","DOI":"10.1093\/database\/baz046","volume":"2019","author":"O Franzen","year":"2019","unstructured":"Franzen O, Gan LM, Bjorkegren JLM. PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data. Database (Oxford). 2019;2019:baz046.","journal-title":"Database (Oxford)."},{"issue":"1","key":"1711_CR47","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41467-022-28803-w","volume":"13","author":"A Ianevski","year":"2022","unstructured":"Ianevski A, Giri AK, Aittokallio T. Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data. Nat Commun. 2022;13(1):1246.","journal-title":"Nat Commun"},{"issue":"D1","key":"1711_CR48","doi-asserted-by":"publisher","first-page":"D596","DOI":"10.1093\/nar\/gkab1020","volume":"50","author":"M Li","year":"2022","unstructured":"Li M, Zhang X, Ang KS, Ling J, Sethi R, Lee NYS, et al. DISCO: a database of deeply integrated human single-cell omics data. Nucleic Acids Res. 2022;50(D1):D596\u2013602.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1711_CR49","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/bioinformatics\/bts714","volume":"29","author":"A McDavid","year":"2013","unstructured":"McDavid A, Finak G, Chattopadyay PK, Dominguez M, Lamoreaux L, Ma SS, et al. Data exploration, quality control and testing in single-cell qPCR-based gene expression experiments. Bioinformatics. 2013;29(4):461\u20137.","journal-title":"Bioinformatics"},{"key":"1711_CR50","unstructured":"Tickle T, Tirosh I, Georgescu C, Brown M, Haas B. inferCNV of the Trinity CTAT Project Klarman Cell Observatory, Broad Institute of MIT and Harvard. 2019. Available from: https:\/\/github.com\/broadinstitute\/inferCNV."},{"issue":"3","key":"1711_CR51","doi-asserted-by":"publisher","first-page":"e3000178","DOI":"10.1371\/journal.pbio.3000178","volume":"17","author":"M Min","year":"2019","unstructured":"Min M, Spencer SL. Spontaneously slow-cycling subpopulations of human cells originate from activation of stress-response pathways. PLoS Biol. 2019;17(3):e3000178.","journal-title":"PLoS Biol"},{"issue":"9","key":"1711_CR52","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.celrep.2017.05.022","volume":"19","author":"T Zerjatke","year":"2017","unstructured":"Zerjatke T, Gak IA, Kirova D, Fuhrmann M, Daniel K, Gonciarz M, et al. Quantitative cell cycle analysis based on an endogenous all-in-one reporter for cell tracking and classification. Cell Rep. 2017;19(9):1953\u201366.","journal-title":"Cell Rep"},{"issue":"8","key":"1711_CR53","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1711_CR54","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41467-023-36439-7","volume":"14","author":"G Malagoli Tagliazucchi","year":"2023","unstructured":"Malagoli Tagliazucchi G, Wiecek AJ, Withnell E, Secrier M. Genomic and microenvironmental heterogeneity shaping epithelial-to-mesenchymal trajectories in cancer. Nat Commun. 2023;14(1):789.","journal-title":"Nat Commun"},{"issue":"1","key":"1711_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13058-022-01503-5","volume":"24","author":"Q Ren","year":"2022","unstructured":"Ren Q, Khoo WH, Corr AP, Phan TG, Croucher PI, Stewart SA. Gene expression predicts dormant metastatic breast cancer cell phenotype. Breast Cancer Res. 2022;24(1):10.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1711_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13058-021-01416-9","volume":"23","author":"JR Ruth","year":"2021","unstructured":"Ruth JR, Pant DK, Pan TC, Seidel HE, Baksh SC, Keister BA, et al. Cellular dormancy in minimal residual disease following targeted therapy. Breast Cancer Res. 2021;23(1):63.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"1711_CR57","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s13058-014-0407-9","volume":"16","author":"Q Cheng","year":"2014","unstructured":"Cheng Q, Chang JT, Gwin WR, Zhu J, Ambs S, Geradts J, et al. A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype. Breast Cancer Res. 2014;16(4):407.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"1711_CR58","doi-asserted-by":"publisher","first-page":"e35569","DOI":"10.1371\/journal.pone.0035569","volume":"7","author":"RS Kim","year":"2012","unstructured":"Kim RS, Avivar-Valderas A, Estrada Y, Bragado P, Sosa MS, Aguirre-Ghiso JA, et al. Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer. PLoS ONE. 2012;7(4):e35569.","journal-title":"PLoS ONE"},{"issue":"3","key":"1711_CR59","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41556-020-0474-3","volume":"22","author":"M Montagner","year":"2020","unstructured":"Montagner M, Bhome R, Hooper S, Chakravarty P, Qin X, Sufi J, et al. Crosstalk with lung epithelial cells regulates Sfrp2-mediated latency in breast cancer dissemination. Nat Cell Biol. 2020;22(3):289\u201396.","journal-title":"Nat Cell Biol"},{"key":"1711_CR60","doi-asserted-by":"crossref","unstructured":"Celik C, Secrier M. EnrichMap: Spatially informed enrichment analysis for functional interpretation of spatial transcriptomics. bioRxiv. 2025:2025.05.30.656960.","DOI":"10.1101\/2025.05.30.656960"},{"issue":"2","key":"1711_CR61","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","volume":"17","author":"R Browaeys","year":"2020","unstructured":"Browaeys R, Saelens W, Saeys Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat Methods. 2020;17(2):159\u201362.","journal-title":"Nat Methods"},{"key":"1711_CR62","unstructured":"Troul\u00e9 K, Petryszak R, Prete M, Cranley J, Harasty A, Tuong ZK, et al. CellPhoneDB v5: inferring cell-cell communication from single-cell multiomics data. arXiv:231104567. 2023."},{"issue":"9","key":"1711_CR63","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/s41556-024-01469-w","volume":"26","author":"D Dimitrov","year":"2024","unstructured":"Dimitrov D, Schafer PSL, Farr E, Rodriguez-Mier P, Lobentanzer S, Badia IMP, et al. LIANA+ provides an all-in-one framework for cell-cell communication inference. Nat Cell Biol. 2024;26(9):1613\u201322.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"1711_CR64","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonzalez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14(11):1083\u20136.","journal-title":"Nat Methods"},{"issue":"5","key":"1711_CR65","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.cels.2021.04.005","volume":"12","author":"D DeTomaso","year":"2021","unstructured":"DeTomaso D, Yosef N. Hotspot identifies informative gene modules across modalities of single-cell genomics. Cell Syst. 2021;12(5):446-56 e9.","journal-title":"Cell Syst"},{"issue":"1","key":"1711_CR66","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13059-024-03428-y","volume":"25","author":"E Withnell","year":"2024","unstructured":"Withnell E, Secrier M. SpottedPy quantifies relationships between spatial transcriptomic hotspots and uncovers environmental cues of epithelial-mesenchymal plasticity in breast cancer. Genome Biol. 2024;25(1):289.","journal-title":"Genome Biol"},{"issue":"5","key":"1711_CR67","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41587-021-01139-4","volume":"40","author":"V Kleshchevnikov","year":"2022","unstructured":"Kleshchevnikov V, Shmatko A, Dann E, Aivazidis A, King HW, Li T, et al. Cell 2location maps fine-grained cell types in spatial transcriptomics. Nat Biotechnol. 2022;40(5):661\u201371.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"1711_CR68","doi-asserted-by":"publisher","first-page":"035001","DOI":"10.1088\/1478-3975\/abbe99","volume":"18","author":"R Elyanow","year":"2021","unstructured":"Elyanow R, Zeira R, Land M, Raphael BJ. STARCH: copy number and clone inference from spatial transcriptomics data. Phys Biol. 2021;18(3):035001.","journal-title":"Phys Biol"},{"issue":"15","key":"1711_CR69","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/onc.2015.254","volume":"35","author":"R Navab","year":"2016","unstructured":"Navab R, Strumpf D, To C, Pasko E, Kim KS, Park CJ, et al. Integrin alpha11beta1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer. Oncogene. 2016;35(15):1899\u2013908.","journal-title":"Oncogene"},{"key":"1711_CR70","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fmolb.2020.00183","volume":"7","author":"Y Liu","year":"2020","unstructured":"Liu Y, Li X, Zheng A, Zhu X, Liu S, Hu M, et al. Predict Ki-67 positive cells in H&E-stained images using deep learning independently from IHC-stained images. Front Mol Biosci. 2020;7:183.","journal-title":"Front Mol Biosci"},{"issue":"10","key":"1711_CR71","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s42256-022-00534-z","volume":"4","author":"F Yang","year":"2022","unstructured":"Yang F, Wang WC, Wang F, Fang Y, Tang DY, Huang JZ, et al. scBERT as a large-scale pretrained deep language model for cell type annotation of single-cell RNA-seq data. Nat Mach Intell. 2022;4(10):852.","journal-title":"Nat Mach Intell."},{"key":"1711_CR72","unstructured":"Pan S, Withnell E, Secrier M. Classifying epithelial-mesenchymal transition states in single cell cancer data using large language models. bioRxiv. 2024:2024.08.16.608311."},{"key":"1711_CR73","unstructured":"Hu EJ, Shen Y, Wallis P, Zeyuan AZ, Li Y, Wang S, et al. LoRA: Low-Rank Adaptation of Large Language Models. arxiv preprint. 2021."},{"issue":"7965","key":"1711_CR74","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"Gavish A, Tyler M, Greenwald AC, Hoefflin R, Simkin D, Tschernichovsky R, et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature. 2023;618(7965):598\u2013606.","journal-title":"Nature"},{"issue":"5","key":"1711_CR75","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41416-024-02928-9","volume":"132","author":"SJ Cutty","year":"2025","unstructured":"Cutty SJ, Hughes FA, Ortega-Prieto P, Desai S, Thomas P, Fets LV, et al. Pro-survival roles for p21(Cip1\/Waf1) in non-small cell lung cancer. Br J Cancer. 2025;132(5):421\u201337.","journal-title":"Br J Cancer"},{"key":"1711_CR76","doi-asserted-by":"crossref","unstructured":"Clarke ZA, Bader GD. MALAT1 expression indicates cell quality in single-cell RNA sequencing data. bioRxiv. 2024:2024.07.14.603469.","DOI":"10.1101\/2024.07.14.603469"},{"key":"1711_CR77","doi-asserted-by":"crossref","unstructured":"O\u2018Connor SA, Garcia L, Hoover R, Patel AP, Bartelle BB, Hugnot J-P, et al. Classifying cell cycle states and a quiescent-like G0 state using single-cell transcriptomics. bioRxiv. 2025:2024.04.16.589816.","DOI":"10.1101\/2024.04.16.589816"},{"issue":"3","key":"1711_CR78","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.celrep.2018.12.071","volume":"26","author":"A Santoro","year":"2019","unstructured":"Santoro A, Vlachou T, Luzi L, Melloni G, Mazzarella L, D\u2019Elia E, et al. p53 loss in breast cancer leads to Myc activation, increased cell plasticity, and expression of a mitotic signature with prognostic value. Cell Rep. 2019;26(3):624-38 e8.","journal-title":"Cell Rep"},{"issue":"11","key":"1711_CR79","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.3390\/cancers13112748","volume":"13","author":"ML Uribe","year":"2021","unstructured":"Uribe ML, Marrocco I, Yarden Y. EGFR in cancer: signaling mechanisms, drugs, and acquired resistance. Cancers (Basel). 2021;13(11):2748.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"1711_CR80","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1038\/s41588-024-01920-6","volume":"56","author":"JS Schiffman","year":"2024","unstructured":"Schiffman JS, D\u2019Avino AR, Prieto T, Pang Y, Fan Y, Rajagopalan S, et al. Defining heritability, plasticity, and transition dynamics of cellular phenotypes in somatic evolution. Nat Genet. 2024;56(10):2174\u201384.","journal-title":"Nat Genet"},{"issue":"2","key":"1711_CR81","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1158\/1541-7786.MCR-21-0702","volume":"20","author":"P Fan","year":"2022","unstructured":"Fan P, Jordan VC. PERK, beyond an unfolded protein response sensor in estrogen-induced apoptosis in endocrine-resistant breast cancer. Mol Cancer Res. 2022;20(2):193\u2013201.","journal-title":"Mol Cancer Res"},{"key":"1711_CR82","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1038\/ncomms7170","volume":"6","author":"MS Sosa","year":"2015","unstructured":"Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes. Nat Commun. 2015;6:6170.","journal-title":"Nat Commun"},{"issue":"15","key":"1711_CR83","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1038\/s41388-018-0624-2","volume":"38","author":"Q Lan","year":"2019","unstructured":"Lan Q, Peyvandi S, Duffey N, Huang YT, Barras D, Held W, et al. Type I interferon\/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer. Oncogene. 2019;38(15):2814\u201329.","journal-title":"Oncogene"},{"issue":"12","key":"1711_CR84","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.tibs.2022.06.007","volume":"47","author":"M Fischer","year":"2022","unstructured":"Fischer M, Schade AE, Branigan TB, Muller GA, DeCaprio JA. Coordinating gene expression during the cell cycle. Trends Biochem Sci. 2022;47(12):1009\u201322.","journal-title":"Trends Biochem Sci"},{"issue":"8","key":"1711_CR85","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrc3556","volume":"13","author":"S Sadasivam","year":"2013","unstructured":"Sadasivam S, DeCaprio JA. The DREAM complex: master coordinator of cell cycle-dependent gene expression. Nat Rev Cancer. 2013;13(8):585\u201395.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1711_CR86","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.15252\/embr.201642195","volume":"17","author":"K Pakos-Zebrucka","year":"2016","unstructured":"Pakos-Zebrucka K, Koryga I, Mnich K, Ljujic M, Samali A, Gorman AM. The integrated stress response. EMBO Rep. 2016;17(10):1374\u201395.","journal-title":"EMBO Rep"},{"issue":"7","key":"1711_CR87","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1083\/jcb.201702058","volume":"216","author":"PM Quiros","year":"2017","unstructured":"Quiros PM, Prado MA, Zamboni N, D\u2019Amico D, Williams RW, Finley D, et al. Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals. J Cell Biol. 2017;216(7):2027\u201345.","journal-title":"J Cell Biol"},{"issue":"11","key":"1711_CR88","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.tem.2017.07.003","volume":"28","author":"IMN Wortel","year":"2017","unstructured":"Wortel IMN, van der Meer LT, Kilberg MS, van Leeuwen FN. Surviving Stress: Modulation of ATF4-Mediated Stress Responses in Normal and Malignant Cells. Trends Endocrinol Metab. 2017;28(11):794\u2013806.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"1711_CR89","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","volume":"20","author":"MS Hipp","year":"2019","unstructured":"Hipp MS, Kasturi P, Hartl FU. The proteostasis network and its decline in ageing. Nat Rev Mol Cell Biol. 2019;20(7):421\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1711_CR90","doi-asserted-by":"publisher","first-page":"e49178","DOI":"10.7554\/eLife.49178","volume":"9","author":"E Mick","year":"2020","unstructured":"Mick E, Titov DV, Skinner OS, Sharma R, Jourdain AA, Mootha VK. Distinct mitochondrial defects trigger the integrated stress response depending on the metabolic state of the cell. Elife. 2020;9:e49178.","journal-title":"Elife"},{"issue":"6","key":"1711_CR91","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.tibs.2022.02.003","volume":"47","author":"PR Smith","year":"2022","unstructured":"Smith PR, Pandit SC, Loerch S, Campbell ZT. The space between notes: emerging roles for translationally silent ribosomes. Trends Biochem Sci. 2022;47(6):477\u201391.","journal-title":"Trends Biochem Sci"},{"issue":"15","key":"1711_CR92","doi-asserted-by":"publisher","first-page":"jcs.259676","DOI":"10.1242\/jcs.259676","volume":"135","author":"R Tomasin","year":"2022","unstructured":"Tomasin R, Bruni-Cardoso A. The role of cellular quiescence in cancer - beyond a quiet passenger. J Cell Sci. 2022;135(15):jcs.259676.","journal-title":"J Cell Sci"},{"issue":"2","key":"1711_CR93","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.coi.2007.02.001","volume":"19","author":"JD Bui","year":"2007","unstructured":"Bui JD, Schreiber RD. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? Curr Opin Immunol. 2007;19(2):203\u20138.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"1711_CR94","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.trecan.2018.10.010","volume":"5","author":"C Prunier","year":"2019","unstructured":"Prunier C, Baker D, Ten Dijke P, Ritsma L. TGF-beta family signaling pathways in cellular dormancy. Trends Cancer. 2019;5(1):66\u201378.","journal-title":"Trends Cancer"},{"issue":"1","key":"1711_CR95","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2021","unstructured":"Derynck R, Turley SJ, Akhurst RJ. TGFbeta biology in cancer progression and immunotherapy. Nat Rev Clin Oncol. 2021;18(1):9\u201334.","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"1711_CR96","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41580-023-00638-3","volume":"24","author":"L Richardson","year":"2023","unstructured":"Richardson L, Wilcockson SG, Guglielmi L, Hill CS. Context-dependent TGFbeta family signalling in cell fate regulation. Nat Rev Mol Cell Biol. 2023;24(12):876\u201394.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1711_CR97","doi-asserted-by":"publisher","first-page":"114127","DOI":"10.1016\/j.biopha.2022.114127","volume":"158","author":"G Miao","year":"2023","unstructured":"Miao G, Zhuo D, Han X, Yao W, Liu C, Liu H, et al. From degenerative disease to malignant tumors: Insight to the function of ApoE. Biomed Pharmacother. 2023;158:114127.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"1711_CR98","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ni944","volume":"4","author":"N Watanabe","year":"2003","unstructured":"Watanabe N, Gavrieli M, Sedy JR, Yang J, Fallarino F, Loftin SK, et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol. 2003;4(7):670\u20139.","journal-title":"Nat Immunol"},{"issue":"7","key":"1711_CR99","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1158\/0008-5472.CAN-20-2352","volume":"81","author":"U Ghoshdastider","year":"2021","unstructured":"Ghoshdastider U, Rohatgi N, Mojtabavi Naeini M, Baruah P, Revkov E, Guo YA, et al. Pan-cancer analysis of ligand-receptor cross-talk in the tumor microenvironment. Cancer Res. 2021;81(7):1802\u201312.","journal-title":"Cancer Res"},{"issue":"1","key":"1711_CR100","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1083\/jcb.200304065","volume":"163","author":"F Zhang","year":"2003","unstructured":"Zhang F, Tom CC, Kugler MC, Ching TT, Kreidberg JA, Wei Y, et al. Distinct ligand binding sites in integrin alpha3beta1 regulate matrix adhesion and cell-cell contact. J Cell Biol. 2003;163(1):177\u201388.","journal-title":"J Cell Biol"},{"issue":"1","key":"1711_CR101","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12885-022-09285-x","volume":"22","author":"Z Guan","year":"2022","unstructured":"Guan Z, Sun Y, Mu L, Jiang Y, Fan J. Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-kappaB signaling activation. BMC Cancer. 2022;22(1):240.","journal-title":"BMC Cancer"},{"issue":"Pt 8","key":"1711_CR102","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1242\/jcs.061903","volume":"123","author":"ML Bochenek","year":"2010","unstructured":"Bochenek ML, Dickinson S, Astin JW, Adams RH, Nobes CD. Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding. J Cell Sci. 2010;123(Pt 8):1235\u201346.","journal-title":"J Cell Sci"},{"issue":"5","key":"1711_CR103","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrc3051","volume":"11","author":"RL Dusek","year":"2011","unstructured":"Dusek RL, Attardi LD. Desmosomes: new perpetrators in tumour suppression. Nat Rev Cancer. 2011;11(5):317\u201323.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1711_CR104","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41597-024-03697-z","volume":"11","author":"WA Weston","year":"2024","unstructured":"Weston WA, Holt JA, Wiecek AJ, Pilling J, Schiavone LH, Smith DM, et al. An image-based screen for secreted proteins involved in breast cancer G0 cell cycle arrest. Sci Data. 2024;11(1):868.","journal-title":"Sci Data"},{"issue":"5","key":"1711_CR105","doi-asserted-by":"publisher","first-page":"e20220610","DOI":"10.1084\/jem.20220610","volume":"220","author":"D Ganguly","year":"2023","unstructured":"Ganguly D, Schmidt MO, Coleman M, Ngo TC, Sorrelle N, Dominguez ATA, et al. Pleiotrophin drives a prometastatic immune niche in breast cancer. J Exp Med. 2023;220(5):e20220610.","journal-title":"J Exp Med"},{"issue":"7971","key":"1711_CR106","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41586-023-06311-1","volume":"619","author":"K Kanemaru","year":"2023","unstructured":"Kanemaru K, Cranley J, Muraro D, Miranda AMA, Ho SY, Wilbrey-Clark A, et al. Spatially resolved multiomics of human cardiac niches. Nature. 2023;619(7971):801\u201310.","journal-title":"Nature"},{"issue":"18","key":"1711_CR107","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1056\/NEJMoa2214963","volume":"388","author":"GW Prager","year":"2023","unstructured":"Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, et al. Trifluridine-tipiracil and bevacizumab in refractory metastatic colorectal cancer. N Engl J Med. 2023;388(18):1657\u201367.","journal-title":"N Engl J Med"},{"issue":"8","key":"1711_CR108","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/15384101.2016.1241929","volume":"16","author":"L Zhang","year":"2017","unstructured":"Zhang L, Xu L, Zhang F, Vlashi E. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer. Cell Cycle. 2017;16(8):737\u201345.","journal-title":"Cell Cycle"},{"key":"1711_CR109","unstructured":"Pan S. G0-FM. GitHub. 2025. https:\/\/github.com\/secrierlab\/G0-FM\/."},{"issue":"1","key":"1711_CR110","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12943-023-01793-z","volume":"22","author":"A Akhmetkaliyev","year":"2023","unstructured":"Akhmetkaliyev A, Alibrahim N, Shafiee D, Tulchinsky E. EMT\/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin? Mol Cancer. 2023;22(1):90.","journal-title":"Mol Cancer"},{"key":"1711_CR111","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcancer.2021.04.021","volume":"78","author":"S Basu","year":"2022","unstructured":"Basu S, Dong Y, Kumar R, Jeter C, Tang DG. Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis. Semin Cancer Biol. 2022;78:90\u2013103.","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"1711_CR112","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","volume":"152","author":"DA Landau","year":"2013","unstructured":"Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS, et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell. 2013;152(4):714\u201326.","journal-title":"Cell"},{"issue":"1","key":"1711_CR113","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41523-026-00903-6","volume":"12","author":"A Yilmaz","year":"2026","unstructured":"Yilmaz A, Haerri L, Granda ME, Coquoz O, Lan Q, Ruegg C. The CXCL10\/CXCR3 axis is essential for sustaining immunological dormancy in triple-negative breast cancer. NPJ Breast Cancer. 2026;12(1):36.","journal-title":"NPJ Breast Cancer"},{"key":"1711_CR114","doi-asserted-by":"publisher","unstructured":"Malcolm JR, Stenning J, Pope J, \u0141ukaszonek J, Rose SF, Smith TE, et al. An ER\u03b1-Dependent Hypoxia Response Defines EMT-Adjacent Tumour Regions and Suppresses the Pro-survival Effects of Amiloride in Estrogen Receptor-Positive Breast Cancer. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.10.03.680339.","DOI":"10.1101\/2025.10.03.680339"},{"key":"1711_CR115","doi-asserted-by":"publisher","unstructured":"Celik C, Secrier M. Single-cell G0 breast cancer atlas. Zenodo. 2026. https:\/\/doi.org\/10.5281\/zenodo.21037473.","DOI":"10.5281\/zenodo.21037473"},{"key":"1711_CR116","unstructured":"Celik C. G0 breast cancer atlas. GitHub. 2026. https:\/\/github.com\/secrierlab\/G0-breast-cancer-atlas."},{"key":"1711_CR117","doi-asserted-by":"publisher","unstructured":"Withnell E. Sample SpottedPy dataset. Zenodo. 2023. https:\/\/doi.org\/10.5281\/zenodo.10371890.","DOI":"10.5281\/zenodo.10371890"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-026-01711-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01711-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01711-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:02:46Z","timestamp":1790982166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13073-026-01711-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":117,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1711"],"URL":"https:\/\/doi.org\/10.1186\/s13073-026-01711-0","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All datasets employed in this study are publicly available and comply with ethical regulations, with approval and informed consent for collection and sharing already obtained by the relevant organisations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"143"}}